XML 83 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Avinza Co-Promotion (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Summary of co-promote termination liability    
Total co-promote termination liability at beginning of period $ 12,534 $ 21,452
Assumed payments made by Pfizer or assignee (3,310) (3,479)
Fair value adjustments due to passage of time 2,522 (5,439)
Total co-promote termination liability at end of period 11,746 12,534
Less: current portion of co-promote termination liability as of December 31, 2013 4,329  
Long-term portion of co-promote termination liability as of December 31, 2013 $ 7,417